Graves Michael 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:09 pm Purchase | 2024-02-12 | 13D | Eagle Pharmaceuticals, Inc. EGRX | Graves Michael | 238,660 1.800% | 238,660 (New Position) | Filing |